Xibing Y. Zhuang

1Department Of Radiation Oncology, 180 Fenglin Road
Zhongshan, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

Baseline Neutrophil-to-Lymphocyte Ratio and Two-Year Incident Distant Metastasis in Stage I-III Lung Cancer: A Single-Center Retrospective Cohort Study.

Baseline Neutrophil-to-Lymphocyte Ratio and Two-Year Incident Distant Metastasis in Stage I-III Lung Cancer: A Single-Center Retrospective Cohort Study.

Journal: Journal of clinical medicine

Published: June 19, 2026

Pharmacovigilance Insights into Route-Stratified Adverse Events of Platinum-Based Drugs.

Pharmacovigilance Insights into Route-Stratified Adverse Events of Platinum-Based Drugs.

Journal: Current medicinal chemistry

Published: February 13, 2026

YC-4-3, a Novel Glycogen Synthase Kinase 3β Inhibitor, Alleviates the Endoplasmic Reticulum Stress of Macrophages in Primary Immune Thrombocytopenia.

YC-4-3, a Novel Glycogen Synthase Kinase 3β Inhibitor, Alleviates the Endoplasmic Reticulum Stress of Macrophages in Primary Immune Thrombocytopenia.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 07, 2024

Changes in immune subsets during chemotherapy as prognosis biomarkers for multiple myeloma patients by longitudinal monitoring.

Changes in immune subsets during chemotherapy as prognosis biomarkers for multiple myeloma patients by longitudinal monitoring.

Journal: Immunologic research

Published: April 05, 2024

Plasma Lipidomics Profiling to Identify the Biomarkers of Diagnosis and Radiotherapy Response for Advanced Non-Small-Cell Lung Cancer Patients.

Plasma Lipidomics Profiling to Identify the Biomarkers of Diagnosis and Radiotherapy Response for Advanced Non-Small-Cell Lung Cancer Patients.

Journal: Journal of lipids

Published: November 30, 2023

Integration of clinical phenoms and metabolomics facilitates precision medicine for lung cancer.

Integration of clinical phenoms and metabolomics facilitates precision medicine for lung cancer.

Journal: Cell biology and toxicology

Published: November 01, 2023

Author Correction: MST4 kinase regulates immune thrombocytopenia by phosphorylating STAT1-mediated M1 polarization of macrophages.

Author Correction: MST4 kinase regulates immune thrombocytopenia by phosphorylating STAT1-mediated M1 polarization of macrophages.

Journal: Cellular & molecular immunology

Published: November 01, 2023

Decreased cyclooxygenase-2 associated with impaired megakaryopoiesis and thrombopoiesis in primary immune thrombocytopenia.

Decreased cyclooxygenase-2 associated with impaired megakaryopoiesis and thrombopoiesis in primary immune thrombocytopenia.

Journal: Journal of translational medicine

Published: May 15, 2023

Lipoprotein lipids and apolipoproteins in primary immune thrombocytopenia: Results from a clinical characteristics and causal relationship verification, potential drug target identification by Mendelian randomization analyses.

Lipoprotein lipids and apolipoproteins in primary immune thrombocytopenia: Results from a clinical characteristics and causal relationship verification, potential drug target identification by Mendelian randomization analyses.

Journal: British journal of haematology

Published: April 21, 2023

MST4 kinase regulates immune thrombocytopenia by phosphorylating STAT1-mediated M1 polarization of macrophages.

MST4 kinase regulates immune thrombocytopenia by phosphorylating STAT1-mediated M1 polarization of macrophages.

Journal: Cellular & molecular immunology

Published: April 05, 2023

Clinical characteristics and correlative factors of dry eye disease associated with graft-versus-host disease

Clinical characteristics and correlative factors of dry eye disease associated with graft-versus-host disease

Journal: [Zhonghua yan ke za zhi] Chinese journal of ophthalmology

Published: April 03, 2023

Low-dose decitabine promotes M2 macrophage polarization in patients with primary immune thrombocytopenia via enhancing KLF4 binding to PPARγ promoter.

Low-dose decitabine promotes M2 macrophage polarization in patients with primary immune thrombocytopenia via enhancing KLF4 binding to PPARγ promoter.

Journal: Clinical and translational medicine

Published: March 26, 2023

Showing 1-12 of 49

Last Updated: 09/26/2026